Literature DB >> 11441070

Fas ligand (CD95L) protects neurons against perforin-mediated T lymphocyte cytotoxicity.

I Medana1, Z Li, A Flügel, J Tschopp, H Wekerle, H Neumann.   

Abstract

Previous work showed that neurons of the CNS are protected against perforin-mediated T cell cytotoxicity, but are susceptible to Fas-mediated apoptosis. In this study, we report that Fas ligand (FasL) expression by neurons is involved in protection against perforin-mediated T cell cytotoxicity. Gene transcripts for FasL were identified in single murine hippocampal neurons by RT-PCR combined with patch clamp electrophysiology, and constitutive expression of FasL protein was confirmed in neurons by immunohistochemistry. Neurons derived from wild-type C57BL/6 (BL6) mice and mutant BL6.gld mice lacking functional FasL were confronted with allogeneic CTLs and continuously monitored in real time for changes in levels of intracellular calcium ([Ca(2+)](i)), an indicator of cytotoxic damage. Perforin-mediated plasma membrane lysis, characterized by rapid, massive [Ca(2+)](i) influx into the target cells within 0.5 h, was not detected in wild-type neurons. In striking contrast, FasL-deficient neurons showed rapid increase in [Ca(2+)](i) within 0.5 h, reflecting perforin-dependent cell lysis. FasL seems to protect neurons by blocking degranulation of CTLs, since CD3-induced release of cytotoxic granules was reduced by coapplication of Fas-specific Abs or rFasL.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11441070     DOI: 10.4049/jimmunol.167.2.674

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

Review 1.  Effector lymphocytes in islet cell autoimmunity.

Authors:  Pere Santamaria
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

2.  Modulation of HLA-G expression in human neural cells after neurotropic viral infections.

Authors:  Monique Lafon; Christophe Prehaud; Françoise Megret; Mireille Lafage; Gaël Mouillot; Michèle Roa; Philippe Moreau; Nathalie Rouas-Freiss; Edgardo D Carosella
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

3.  Up-regulation of Fas ligand (FasL) in the central nervous system: a mechanism of immune evasion by rabies virus.

Authors:  Leïla Baloul; Serge Camelo; Monique Lafon
Journal:  J Neurovirol       Date:  2004-12       Impact factor: 2.643

Review 4.  CD8(+) T cells in multiple sclerosis.

Authors:  Aleksandar Denic; Bharath Wootla; Moses Rodriguez
Journal:  Expert Opin Ther Targets       Date:  2013-07-06       Impact factor: 6.902

Review 5.  Contribution of CD8 T lymphocytes to the immuno-pathogenesis of multiple sclerosis and its animal models.

Authors:  Lennart T Mars; Philippe Saikali; Roland S Liblau; Nathalie Arbour
Journal:  Biochim Biophys Acta       Date:  2010-07-15

6.  Cytotoxicity mediated by the Fas ligand (FasL)-activated apoptotic pathway in stem cells.

Authors:  Julia Mazar; Molly Thomas; Ludmila Bezrukov; Alexander Chanturia; Gulcin Pekkurnaz; Shurong Yin; Sergei A Kuznetsov; Pamela G Robey; Joshua Zimmerberg
Journal:  J Biol Chem       Date:  2009-06-15       Impact factor: 5.157

7.  Characterization of three human cell line models for high-throughput neuronal cytotoxicity screening.

Authors:  Zhi-Bin Tong; Helena Hogberg; David Kuo; Srilatha Sakamuru; Menghang Xia; Lena Smirnova; Thomas Hartung; David Gerhold
Journal:  J Appl Toxicol       Date:  2016-05-03       Impact factor: 3.446

8.  Immature and neurally differentiated mouse embryonic stem cells do not express a functional Fas/Fas ligand system.

Authors:  Gabriella Brunlid; Jan Pruszak; Benjamin Holmes; Ole Isacson; Kai-Christian Sonntag
Journal:  Stem Cells       Date:  2007-07-05       Impact factor: 6.277

Review 9.  Inflammation on the mind: visualizing immunity in the central nervous system.

Authors:  Silvia S Kang; Dorian B McGavern
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

Review 10.  [New understanding of the immunopathogenesis of multiple sclerosis].

Authors:  B Rosche; B Kieseier; H-P Hartung; B Hemmer
Journal:  Nervenarzt       Date:  2003-08       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.